Document And Entity Information
Document And Entity Information - shares | 6 Months Ended | |
Sep. 30, 2018 | Nov. 12, 2018 | |
Document and Entity Information [Abstract] | ||
Entity Registrant Name | TEL INSTRUMENT ELECTRONICS CORP | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --03-31 | |
Entity Common Stock, Shares Outstanding | 3,255,887 | |
Amendment Flag | false | |
Entity Central Index Key | 96,885 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Sep. 30, 2018 | |
Document Fiscal Year Focus | 2,019 | |
Document Fiscal Period Focus | Q2 | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Ex Transition Period | false |
CONDENSED CONSOLIDATED BALANCE
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) | Sep. 30, 2018 | Mar. 31, 2018 |
Current assets: | ||
Cash and cash equivalents | $ 278,443 | $ 307,812 |
Accounts receivable, net | 769,553 | 1,095,049 |
Inventories, net | 3,762,164 | 4,269,934 |
Restricted cash to support appeal bond | 2,002,873 | 2,000,866 |
Prepaid expenses and other current assets | 130,835 | 147,746 |
Total current assets | 6,943,868 | 7,821,407 |
Equipment and leasehold improvements, net | 142,917 | 180,763 |
Deferred tax asset, net | 63,500 | 63,500 |
Other long-term assets | 35,109 | 35,109 |
Total assets | 7,185,394 | 8,100,779 |
Current liabilities: | ||
Current portion of long-term debt | 0 | 2,124 |
Line of credit | 840,000 | 1,000,000 |
Capital lease obligations – current portion | 7,200 | 6,875 |
Accounts payable and accrued liabilities | 2,355,269 | 2,580,383 |
Deferred revenues – current portion | 344,164 | 60,051 |
Accrued legal damages | 5,144,644 | 5,059,990 |
Accrued payroll, vacation pay and payroll taxes | 363,588 | 447,863 |
Total current liabilities | 9,054,865 | 9,157,286 |
Capital lease obligations – long-term | 3,202 | 6,885 |
Deferred revenues – long-term | 296,526 | 337,676 |
Total liabilities | 9,354,593 | 9,501,847 |
Commitments and contingencies | ||
Stockholders’ deficit: | ||
Preferred stock, 1,000,000 shares authorized, par value $0.10 per share, 500,000 shares 8% Cumulative Series A Convertible Preferred issued and Outstanding | 3,155,998 | 3,035,998 |
Common stock, 4,000,000 shares authorized, par value $0.10 per share, 3,255,887 shares issued and outstanding, respectively | 325,586 | 325,586 |
Paid-in capital in excess of par value, common stock | 8,096,327 | 8,046,975 |
Accumulated deficit | (13,747,110) | (12,809,627) |
Total stockholders’ deficit | (2,169,199) | (1,401,068) |
Total liabilities and stockholders’ deficit | $ 7,185,394 | $ 8,100,779 |
CONDENSED CONSOLIDATED BALANC_2
CONDENSED CONSOLIDATED BALANCE SHEETS (Parentheticals) - $ / shares | Sep. 30, 2018 | Mar. 31, 2018 |
Preferred stock, shares authorized | 1,000,000 | 0 |
Preferred stock, par value (in Dollars per share) | $ 0.10 | |
Preferred stock, shares issued | 500,000 | 0 |
Preferred stock, shares outstanding | 500,000 | 0 |
Common stock, par value (in Dollars per share) | $ 0.10 | $ 0.10 |
Common stock, shares issued | 3,255,887 | 3,255,887 |
Common stock, shares outstanding | 3,255,887 | 3,255,887 |
Common stock, shares authorized | 4,000,000 | 4,000,000 |
CONDENSED CONSOLIDATED STATEMEN
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($) | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Net sales | $ 2,222,941 | $ 1,787,165 | $ 4,037,155 | $ 5,329,242 |
Cost of sales | 1,223,728 | 1,387,295 | 2,556,629 | 3,688,082 |
Gross margin | 999,213 | 399,870 | 1,480,526 | 1,641,160 |
Operating expenses: | ||||
Selling, general and administrative | 555,411 | 626,395 | 1,121,936 | 1,332,681 |
Litigation expenses | 35,848 | 43,333 | 75,119 | 425,845 |
Legal damages | 0 | 2,100,000 | 0 | 2,100,000 |
Engineering, research and development | 503,380 | 529,667 | 1,020,703 | 1,144,940 |
Total operating expenses | 1,094,639 | 3,299,395 | 2,217,758 | 5,003,466 |
Loss from operations | (95,426) | (2,899,525) | (737,232) | (3,362,306) |
Interest income | 1,009 | 0 | 2,007 | 0 |
Proceeds from life insurance | 0 | 0 | 0 | 92,678 |
Amortization of deferred financing costs | 0 | (1,357) | 0 | (2,714) |
Change in fair value of common stock warrants | 0 | (5,000) | 0 | 90,000 |
Interest expense - judgement | (72,003) | 0 | (143,223) | 0 |
Interest expense | (24,990) | (14,707) | (59,035) | (24,338) |
Total other (expense) income | (95,984) | (21,064) | (200,251) | 155,626 |
Loss income before income taxes | (191,410) | (2,920,589) | (937,483) | (3,206,680) |
Income tax expense | 0 | 0 | 0 | 0 |
Net loss | (191,410) | (2,920,589) | (937,483) | (3,206,680) |
Preferred dividends | 60,000 | 0 | 120,000 | 0 |
Net loss attributable to common shareholders | $ (251,410) | $ (2,920,589) | $ (1,057,483) | $ (3,206,680) |
Basic loss per common share (in Dollars per share) | $ (0.08) | $ (0.90) | $ (0.32) | $ (0.98) |
Diluted loss per common share (in Dollars per share) | $ (0.08) | $ (0.90) | $ (0.32) | $ (0.98) |
Weighted average shares outstanding: | ||||
Basic (in Shares) | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 |
Diluted (in Shares) | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 |
CONDENSED CONSOLIDATED STATEM_2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) | 6 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Net loss | $ (937,483) | $ (3,206,680) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Depreciation and amortization | 37,846 | 38,112 |
Provision for inventory obsolescence | 45,000 | 25,000 |
Amortization of deferred financing costs | 0 | 2,714 |
Change in fair value of common stock warrant | 0 | (90,000) |
Non-cash stock-based compensation | 13,177 | 15,815 |
Changes in assets and liabilities: | ||
Decrease in accounts receivable | 325,496 | 489,105 |
Decrease (increase) in inventories | 462,770 | (273,198) |
Decrease in prepaid expenses & other assets | 16,911 | 108,582 |
Increase in restricted cash for appeal bond | (2,007) | 0 |
(Decrease) increase in accounts payable and other accrued expenses | (225,114) | 284,611 |
Decrease in federal and state taxes | 0 | (4,105) |
Decrease in accrued payroll, vacation pay & withholdings | (84,275) | (110,397) |
Increase (decrease) increase in deferred revenues | 242,963 | (64,420) |
Increase in accrued legal damages | 84,654 | 2,100,000 |
Net cash used in operating activities | (20,062) | (684,861) |
Cash flows from investing activities: | ||
Purchases of equipment | 0 | (53,402) |
Net cash used in investing activities | 0 | (53,402) |
Cash flows from financing activities: | ||
Proceeds from line of credit | 0 | 800,000 |
Repayment of line of credit | (160,000) | 0 |
Repayment of long-term debt | (2,124) | (216,313) |
Proceeds from short-swing profits from an investor | 156,175 | 0 |
Repayment of capitalized lease obligations | (3,358) | (3,062) |
Net cash (used in) provided by financing activities | (9,307) | 580,625 |
Net decrease in cash and cash equivalents | (29,369) | (157,638) |
Cash and cash equivalents at beginning of period | 307,812 | 287,873 |
Cash and cash equivalents at end of period | 278,443 | 130,235 |
Supplemental cash flow information: | ||
Taxes paid | 0 | 5,000 |
Interest paid | $ 28,278 | $ 36,477 |
Note 1 - Basis of Presentation
Note 1 - Basis of Presentation | 6 Months Ended |
Sep. 30, 2018 | |
Disclosure Text Block [Abstract] | |
Basis of Accounting [Text Block] | Note 1 – Basis of Presentation In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments necessary to present fairly the financial position of Tel-Instrument Electronics Corp. (the “Company” or “TIC” or “Tel”) as of September 30, 2018, the results of operations for the three and six months ended September 30, 2018 and September 30, 2017, and statements of cash flows for the six months ended September 30, 2018 and September 30, 2017. These results are not necessarily indicative of the results to be expected for the full year. The financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include disclosures normally made in an Annual Report on Form 10-K. The March 31, 2018 balance sheet included herein was derived from the audited financial statements included in the Company’s Annual Report on Form 10-K as of that date. Accordingly, the financial statements included herein should be reviewed in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2018, as filed with the United States Securities and Exchange Commission (the “SEC”) on July 16, 2018 (the “Annual Report). |
Note 2 - Liquidity and Going Co
Note 2 - Liquidity and Going Concern | 6 Months Ended |
Sep. 30, 2018 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Substantial Doubt about Going Concern [Text Block] | Note 2 – Liquidity and Going Concern These consolidated financial statements have been prepared in conformity with GAAP, which contemplates continuation of the Company as a going concern. As reflected in the accompanying financial statements, for the year ended March 31, 2018, the Company incurred a net loss of $4,322,311 and a loss of $937,483 for the six months ended September 30, 2018. As discussed in Note 14 to the Notes to the Condensed Consolidated Financial Statements, the Company has recorded estimated damages to date of $5,144,644, including interest and additional fees, as a result of the jury verdict associated with the Aeroflex litigation. The Company has filed for an appeal. The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex. The Court conducted further hearings on the Company’s post-trial motions which sought to reduce the damages award of $2.8 million, as well as the punitive damages claim. The Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages. The Company has filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. The Court heard these motions and such motions were denied. The Company has filed for the appeal. The Company has posted a $2,000,000 bond for the appeal. This $2 million bond amount will remain in place during the appeal process (See Note 14). The Company believes it has solid grounds to appeal this verdict. The appeal process is expected to take several years to complete. However, the Company cannot predict the timing or the outcome of the appeal. The Company believes it has sufficient financing in place to fund its plans for the next twelve months due in part to recent large orders it has received that should return the Company to profitability. The Company’s line of credit agreement expires on May 31, 2019. On October 5, 2018, the Company entered into a definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock (the “ Series B Preferred The financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities and commitments in the normal course of business. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. |
Note 3 - Summary of Significant
Note 3 - Summary of Significant Accounting Policies | 6 Months Ended |
Sep. 30, 2018 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies [Text Block] | Note 3 – Summary of Significant Accounting Policies During the six months ended September 30, 2018, there have been no material changes in the Company’s significant accounting policies to those previously disclosed in the Annual Report. |
Note 4 - Accounts Receivable, n
Note 4 - Accounts Receivable, net | 6 Months Ended |
Sep. 30, 2018 | |
Receivables [Abstract] | |
Loans, Notes, Trade and Other Receivables Disclosure [Text Block] | Note 4 – Accounts Receivable, net The following table sets forth the components of accounts receivable: September 30, 2018 March 31, 2018 Government $ 436,180 $ 998,522 Commercial 340,873 104,027 Less: Allowance for doubtful accounts (7,500 ) (7,500 ) $ 769,553 $ 1,095,049 |
Note 5 - Restricted Cash to sup
Note 5 - Restricted Cash to support appeal bond | 6 Months Ended |
Sep. 30, 2018 | |
Cash and Cash Equivalents [Abstract] | |
Cash and Cash Equivalents Disclosure [Text Block] | Note 5 – Restricted Cash to support appeal bond The Company transferred $2,000,000 to a restricted cash account to secure a letter of credit which was used for collateral for the appeal bond (See Notes 13 and 14). |
Note 6 - Inventories, net
Note 6 - Inventories, net | 6 Months Ended |
Sep. 30, 2018 | |
Inventory Disclosure [Abstract] | |
Inventory Disclosure [Text Block] | Note 6 – Inventories, net Inventories consist of: September 30, 2018 March 31, 2018 Purchased parts $ 2,956,459 $ 3,571,874 Work-in-process 1,254,607 1,051,725 Finished goods 16,098 66,335 Less: Inventory reserve (465,000 ) (420,000 ) $ 3,762,164 $ 4,269,934 |
Note 7 - Net Loss per Share
Note 7 - Net Loss per Share | 6 Months Ended |
Sep. 30, 2018 | |
Earnings Per Share [Abstract] | |
Earnings Per Share [Text Block] | Note 7 – Net Loss per Share Net income (loss) per share has been computed according to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC 260”), “Earnings per Share,” which requires a dual presentation of basic and diluted income (loss) per share (“EPS”). Basic EPS represents net income (loss) divided by the weighted average number of common shares outstanding during a reporting period. Diluted EPS reflects the potential dilution that could occur if securities, including warrants and options, were converted into common stock. The dilutive effect of outstanding warrants and options is reflected in earnings per share by use of the treasury stock method. In applying the treasury stock method for stock-based compensation arrangements, the assumed proceeds are computed as the sum of the amount the employee must pay upon exercise and the amounts of average unrecognized compensation costs attributed to future services. Three Months Ended Three Months Ended September 30, 2018 September 30, 2017 Basic net loss per share computation: Net loss $ (191,410 ) $ (2,920,589 ) Add: Preferred dividends (60,000 ) - Net loss attributable to common shareholders (251,410 ) (2,920,589 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Basic net loss per share $ (0.08 ) $ (0.90 ) Diluted net loss per share computation Net loss income $ (191,410 ) $ (2,920,589 ) Add: Preferred dividends (60,000 ) - Diluted loss income $ (251,410 ) (2,920,589 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Incremental shares attributable to the assumed exercise of outstanding stock options and warrants - - Total adjusted weighted-average shares 3,255,887 3,255,887 Diluted net loss per share $ (0.08 ) $ (0.90 ) Six Months Ended Six Months Ended Septe mber 30, 2018 September 30, 2017 Basic net loss per share computation: Net loss $ (937,483 ) $ (3,206,680 ) Add: Preferred dividends (120,000 ) - Net loss attributable to common shareholders (1,057,483 ) (3,206,680 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Basic net income per share $ (0.32 ) $ (0.98 ) Diluted net loss per share computation Net loss $ (937,483 ) $ (3,206,680 ) Add: Preferred dividends (120,000 ) - Diluted loss attributable to common shareholders $ (1,057,483 ) (3,206,680 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Incremental shares attributable to the assumed exercise of outstanding stock options and warrants - - Total adjusted weighted-average shares 3,255,887 3,255,887 Diluted net loss per share $ (0.32 ) $ (0.98 ) The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share: September 30, 2018 September 30, 2017 Convertible preferred stock 1,070,222 - Stock options 42,500 77,000 Warrants 50,000 50,000 1,162,722 127,000 |
Note 8 - Long-Term Debt
Note 8 - Long-Term Debt | 6 Months Ended |
Sep. 30, 2018 | |
Disclosure Text Block [Abstract] | |
Long-term Debt [Text Block] | Note 8 – Long-Term Debt Term Loans with Bank of America In July 2015, the Company entered into a term loan in the amount of $18,000 with Bank of America. The term loan was for three years, and matured in July 2018. Monthly payments were $536 including interest at 4.5%. The term loan was collateralized by substantially all of the assets of the Company. At September 30, 2018 and March 31, 2018, the outstanding balances were $-0- and $2,124, respectively. This loan was paid in full in July 2018. |
Note 9 - Line of Credit
Note 9 - Line of Credit | 6 Months Ended |
Sep. 30, 2018 | |
Debt Disclosure [Abstract] | |
Debt Disclosure [Text Block] | Note 9 – Line of Credit On March 21, 2016, the Company entered into a line of credit agreement with Bank of America, which expired March 31, 2017. In March 2017, the Company extended until March 31, 2018. The line provided a revolving credit facility with borrowing capacity of up to $1,000,000. There were no covenants or borrowing base calculations associated with this line of credit. On August 29, 2018, the Company entered a Loan Modification Agreement (the “Agreement”) with the bank. The Company had been working with the bank and had paid $100,000 to the bank to lower the outstanding balance to $900,000 at the signing of the Agreement. The Agreement has the following provisions: 1) The Company to make an additional principal payment of $50,000 by October 1, 2018. (The Company made this payment.) 2) Borrowing base calculation tied to accounts receivable and inventories. 3) The Agreement expires May 31, 2019. 4) Interest on any outstanding balances is payable monthly at an annual interest rate equal to the LIBOR (London Interbank Offered Rates) Daily Floating plus 3.75 percentage points. The Company’s interest rate was 5.915% at September 30, 2018. 5) The line is collateralized by substantially all of the assets of the Company. 6) The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019. 7) Beginning with the fiscal year ended March 31, 2019, the Company must maintain a debt service coverage ratio. During the six months ended September 30, 2018, the Company repaid $160,000 against this line of credit. As of September 30, 2018 and March 31, 2018, the outstanding balances were $840,000 and $1,000,000, respectively. As of September 30, 2018 the remaining availability under this line is $-0-. |
Note 10 - Segment Information
Note 10 - Segment Information | 6 Months Ended |
Sep. 30, 2018 | |
Segment Reporting [Abstract] | |
Segment Reporting Disclosure [Text Block] | Note 10 – Segment Information In accordance with FASB ASC 280, “Disclosures about Segments of an Enterprise and related information”, the Company determined it has two reportable segments - avionics government and avionics commercial. There are no inter-segment revenues. The Company is organized primarily on the basis of its avionics products. The avionics government segment consists primarily of the design, manufacture, and sale of test equipment to the U.S. and foreign governments and militaries either directly or through distributors. The avionics commercial segment consists of design, manufacture, and sale of test equipment to domestic and foreign airlines, directly or through commercial distributors, and to general aviation repair and maintenance shops. The Company develops and designs test equipment for the avionics industry and as such, the Company’s products and designs cross segments. Management evaluates the performance of its segments and allocates resources to them based on gross margin. The Company’s general and administrative costs and sales and marketing expenses, and engineering costs are not segment specific. As a result, all operating expenses are not managed on a segment basis. Net interest includes expenses on debt and income earned on cash balances, both maintained at the corporate level. The table below presents information about reportable segments within the avionics business for the three and six month periods ending September 30, 2018 and 2017: Three Months Ended September 30, 2018 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 1,284,099 $ 938,842 $ 2,222,941 $ - $ 2,222,941 Cost of sales 714,590 509,138 1,223,728 - 1,223,728 Gross margin 569,509 429,704 999,213 - 999,213 Engineering, research, and development 503,380 - 503,380 Selling, general and administrative 194,179 361,232 555,411 Litigation costs 35,848 35,848 Interest income - (1,009 ) (1,009 ) Interest expense - judgment 72,003 72,003 Interest expense - 24,990 24,990 Total expenses 697,559 493,064 1,190,623 Income (loss) before income taxes $ 301,654 $ (493,064 ) $ (191,410 ) Three Months Ended September 30, 2017 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 1,028,693 $ 758,472 $ 1,787,165 $ - $ 1,787,165 Cost of sales 660,589 726,706 1,387,295 - 1,387,295 Gross margin 368,104 31,766 399,870 - 399,870 Engineering, research, and development 529,667 - 529,667 Selling, general and administrative 277,518 348,877 626,395 Litigation costs 43,333 43,333 Legal damages 2,100,000 2,100,000 Amortization of deferred financing costs - 1,357 1,357 Change in fair value of common stock warrants - 5,000 5,000 Proceeds from life insurance - - Interest expense, net - 14,707 14,707 Total expenses 807,185 2,513,274 3,320,459 Loss before income taxes $ (407,315 ) $ (2,513,274 ) $ (2,920,589 ) Six Months Ended September 30, 2018 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 2,376,681 $ 1,660,474 $ 4,037,155 $ - $ 4,037,155 Cost of sales 1,475,844 1,080,785 2,556,629 - 2,556,629 Gross margin 900,837 579,689 1,480,526 - 1,480,526 Engineering, research, and development 1,020,703 - 1,020,703 Selling, general and administrative 411,307 710,629 1,121,936 Litigation costs 75,119 75,119 Interest income - (2,007 ) (2,007 ) Interest expense - judgment 143,223 143,223 Interest expense - 59,035 59,035 Total expenses 1,432,010 985,999 2,418,009 Income (loss) before income taxes $ 48,516 $ (985,999 ) $ (937,483 ) Six Months Ended September 30, 2017 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 4,001,019 $ 1,328,223 $ 5,329,242 $ - $ 5,329,242 Cost of sales 2,475,742 1,212,340 3,688,082 - 3,688,082 Gross margin 1,525,277 115,883 1,641,160 - 1,641,160 Engineering, research, and development 1,144,940 - 1,144,940 Selling, general and administrative 636,185 696,496 1,332,681 Litigation costs 425,845 425,845 Legal damages 2,100,000 2,100,000 Amortization of deferred financing costs - 2,714 2,714 Change in fair value of common stock warrants - (90,000 ) (90,000 ) Proceeds from life insurance (92,678 ) (92,678 ) Interest expense, net - 24,338 24,338 Total expenses 1,781,125 3,066,715 4,847,840 Loss before income taxes $ (139,965 ) $ (3,066,715 ) $ (3,206,680 ) |
Note 11 - Income Taxes
Note 11 - Income Taxes | 6 Months Ended |
Sep. 30, 2018 | |
Income Tax Disclosure [Abstract] | |
Income Tax Disclosure [Text Block] | Note 11 – Income Taxes FASB ASC 740-10, “Accounting for Uncertainty in Income Taxes” (“ASC 740-10”) prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not have any unrecognized tax benefits. The tax effect of temporary differences, primarily net operating loss carryforwards, asset reserves and accrued liabilities, gave rise to the Company’s deferred tax asset. Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. The Company has approximately $3.5 million in deferred tax assets, and we have provided a valuation allowance that offsets the majority of the asset. The inability to obtain new profitable contracts or the failure of the Company’s engineering development efforts could reduce estimates of future profitability, which could affect the Company’s ability to realize the deferred tax assets. Due to the adverse judgment and the resulting losses the past few years, management has established a valuation allowance against this deferred tax asset. This valuation allowance could be reversed when the Company returns to profitability, and can demonstrate that it will be able to utilize the deferred tax asset. |
Note 12 - Fair Value Measuremen
Note 12 - Fair Value Measurements | 6 Months Ended |
Sep. 30, 2018 | |
Fair Value Disclosures [Abstract] | |
Fair Value Disclosures [Text Block] | Note 1 2 – Fair Value Measurements FASB ASC 820-10, Fair Value Measurements and Disclosures (“ASC 820-10”) defines fair value, establishes a framework for measuring fair value under generally accepted accounting principles and expands disclosures about fair value measurements. As defined in ASC 820-10, fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The Company utilizes market data or assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated, or generally unobservable. The Company classifies fair value balances based on the observation of those inputs. ASC 820-10 establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurement) and the lowest priority to unobservable inputs (level 3 measurement). The three levels of the fair value hierarchy defined by ASC 820-10 are as follows: - Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. - Level 2 – Pricing inputs are other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reported date. Level 2 includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. - Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The valuation techniques that may be used to measure fair value are as follows: ● Market approach — Uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. ● Income approach — Uses valuation techniques to convert future amounts to a single present amount based on current market expectations about those future amounts, including present value techniques, option-pricing models and excess earnings method. ● Cost approach — Based on the amount that currently would be required to replace the service capacity of an asset (replacement cost). The carrying value of the Company’s borrowings is a reasonable estimate of its fair value as borrowings under the Company’s credit facility reflect currently available terms and conditions for similar debt. The Company has warrants with an outside investor to purchase 50,000 shares of the Company’s common stock at an exercise price of $3.35 per share or exercising the “put option” to the Company. These warrants are measured at fair value. The warrant liability of the 50,000 warrants was $-0- at September 30, 2018 and at March 31, 2018. |
Note 13 - Series A 8% Convertib
Note 13 - Series A 8% Convertible Preferred Stock | 6 Months Ended |
Sep. 30, 2018 | |
Disclosure Text Block Supplement [Abstract] | |
Preferred Stock [Text Block] | Note 1 3 – Series A 8% Convertible Preferred Stock On November 14, 2017, the Company entered into definitive subscription agreements with an accredited investor, pursuant to which the investor purchased an aggregate of 500,000 shares of the Company’s Series A Preferred Stock (the “Series A Preferred”) for an aggregate of $3 million. The Company intends to use such proceeds for the payment of any Court judgment and/or settlement related to the Aeroflex Wichita, Inc. litigation, working capital purposes, and for payment of fees and expenses associated with this transaction. The Closing occurred following the satisfaction of customary closing conditions. The securities issued pursuant to the Subscription Agreements were not registered under the Securities Act of 1933, as amended (the “Securities Act”), but qualified for exemption under Section 4(a)(2) of the Securities Act. The securities were exempt from registration under Section 4(a)(2) of the Securities Act because the issuance of such securities by the Company did not involve a “public offering,” as defined in Section 4(a)(2) of the Securities Act, due to the insubstantial number of persons involved in the transaction, size of the offering, manner of the offering and number of securities offered. The Company did not undertake an offering in which it sold a high number of securities to a high number of investors. In addition, these shareholders had the necessary investment intent as required by Section 4(a)(2) of the Securities Act since they agreed to, and received, share certificates bearing a legend stating that such securities are restricted pursuant to Rule 144 of the Securities Act. This restriction ensures that these securities would not be immediately redistributed into the market and therefore not be part of a “public offering.” Based on an analysis of the above factors, the Company has met the requirements to qualify for exemption under Section 4(a)(2) of the Securities Act. The shares of Series A Preferred have a stated value of $6.00 per share (the “Series A Stated Value”) and are convertible into Common Stock at a price of $3.00 per share. The holders of shares of the Series A Preferred shall be entitled to receive dividends out of any assets legally available, to the extent permitted by New Jersey law, at an annual rate equal to 8% of the Series A Stated Value of such shares of Series A Preferred, calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series A Preferred, payable quarterly in cash. Any unpaid dividends shall accrue at the same rate. To the extent not paid on the last day of March, June, September and December of each calendar year, all dividends on any share of Series A Preferred shall accumulate whether or not declared by the Board and shall remain accumulated dividends until paid. As of March 31, 2018, the Company accrued $90,667 for dividends. Since there were not sufficient authorized shares to allow for full conversion of the preferred stock into common stock at December 31, 2017, preferred stock was classified as mezzanine equity. At the January 2018 annual meeting approval was obtained for the additional authorized shares. As such, preferred stock will now be classified as permanent stockholders’ equity. The Holders will vote together with the holders of the Company’s Common Stock on an as-converted basis on each matter submitted to a vote of holders of Common Stock (whether at a meeting of shareholders or by written consent). Effective beginning on the third anniversary of the Original Issue Date, and upon 30 days’ written notice to the Holders of Series A Preferred, the Company may, in its sole discretion, redeem the Series A Preferred at the aggregate Series A Stated Value plus any accrued and accumulated but unpaid dividends. |
Note 14 - Litigation
Note 14 - Litigation | 6 Months Ended |
Sep. 30, 2018 | |
Disclosure Text Block Supplement [Abstract] | |
Legal Matters and Contingencies [Text Block] | Note 1 4 – Litigation Contingencies are recorded in the consolidated financial statements when it is probable that a liability will be incurred and the amount of the loss is reasonably estimable, or otherwise disclosed, in accordance with Accounting Standards Codification 450, Contingencies (ASC 450). Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. In the event the Company determines that a loss is not probable, but is reasonably possible, and it becomes possible to develop what the Company believes to be a reasonable range of possible loss, then the Company will include disclosures related to such matter as appropriate and in compliance with ASC 450. To the extent there is a reasonable possibility that the losses could exceed the amounts already accrued, the Company will, when applicable, adjust the accrual in the period the determination is made, disclose an estimate of the additional loss or range of loss or if the amount of such adjustment cannot be reasonably estimated, disclose that an estimate cannot be made. On March 24, 2009, Aeroflex Wichita, Inc. (“Aeroflex”) filed a petition against the Company and two of its employees in the District Court located in Sedgwick County, Kansas, Case No. 09 CV 1141 (the “Aeroflex Action”), alleging that the Company and its two employees misappropriated Aeroflex’s proprietary technology in connection with the Company winning a substantial contract from the U.S. Army, to develop new Mode-5 radar test sets and kits to upgrade the existing TS-4530 radar test sets to Mode 5 (the “Award”). Aeroflex’s petition, seeking injunctive relief and damages, alleges that in connection with the Award, the Company and its named employees misappropriated Aeroflex’s trade secrets; tortiously interfered with Aeroflex’s business relationship; conspired to harm Aeroflex and tortiously interfered with Aeroflex’s contract. The central basis of all the claims in the Aeroflex Action is that the Company misappropriated and used Aeroflex proprietary technology and confidential information in winning the Award. In February 2009, subsequent to the Company winning the Award, Aeroflex filed a protest of the Award with the Government Accounting Office (“GAO”). In its protest, Aeroflex alleged, inter alia, that the Company used Aeroflex’s proprietary technology in order to win the Award, the same material allegations as were later alleged in the Aeroflex Action. On or about March 17, 2009, the U.S. Army Contracts Attorney and the U.S. Army Contracting Officer each filed a statement with the GAO, expressly rejecting Aeroflex’s allegations that the Company used or infringed on Aeroflex’s proprietary technology in winning the Award, and concluding that the Company had used only its own proprietary technology. On April 6, 2009, Aeroflex withdrew its protest. In December 2009, the Kansas District Court dismissed the Aeroflex Action on jurisdiction grounds. Aeroflex appealed this decision. In May 2012, the Kansas Supreme Court reversed the decision and remanded the Aeroflex Action to the Kansas District Court for further proceedings. On May 23, 2016, the Company filed a motion for summary judgment based on Aeroflex’s lack of jurisdictional standing to bring the case. The motion asserts that Aeroflex does not own the intellectual property at issue since it is a bare licensee of Northrop Grumman. Northrop Grumman has declined to join this suit as plaintiff. Aeroflex lacks standing to sue alone. Also, the motion raises the fact that Aeroflex allowed the license to expire. Aeroflex’s claims are either moot or Aeroflex lacks standing to sue for damages alleged to have accrued after the license ended in 2011. The motion for summary judgment was denied. The Aeroflex trial on remand in the Kansas District Court began in March 2017. After a nine-week trial, the jury rendered its verdict. The jury found no misappropriation of Aeroflex trade secrets but it did rule that the Company tortiously interfered with a prospective business opportunity and awarded damages of $1.3 million for lost profits. The jury also ruled that Tel tortiously interfered with Aeroflex’s non-disclosure agreements with two former Aeroflex employees and awarded damages of $1.5 million for lost profits, resulting in total damages against the Company of $2.8 million. The jury also found that the former Aeroflex employees breached their non-disclosure agreements with Aeroflex and awarded damages against these two individuals totaling $525,000. The jury also decided that punitive damages should be allowed against the Company. Following the verdict, the Company filed a motion for judgment as a matter of law. In the motion, the Company renewed its motion for judgment on Aeroflex’s tortious interference with prospective business opportunity claim arguing that such claim is barred by the statute of limitations. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. Additionally, the motion for judgment addresses inconsistency between the awards against the former Aeroflex employees for breach of the non-disclosure agreements and the award against the Company for interfering with those agreements. Alternatively, the motion asserts there is insufficient evidence supporting the lost profit award on that claim. During July 2017, the Court heard the Company’s motion for judgment as well as conducting a hearing as to the amount of a punitive damages award. Kansas statutes limit punitive damages to a maximum of $5 million. Aeroflex submitted a motion to the Court requesting that the judge award punitive damages at the maximum $5 million amount. In October 2017, the Court denied the Company’s motions and awarded Aeroflex an additional $2.1 million of punitive damages, which brings the total Tel damages awarded in this case to approximately $4.9 million. The Company filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. A hearing on this motion was held. The Judge rejected all of our arguments and declined to order a new trial. We filed the appeal document the week of May 28. The Company has posted a $2,000,000 bond. This $2 million bond amount will remain in place during the appeal process (See Note 5). The Company believes it has solid grounds to appeal this verdict. The appeal process is anticipated to take several years to complete. On July 5, 2018, Plaintiff Aeroflex Wichita, Inc. filed a Notice of Cross-Appeal which is contingent in nature in that it seeks a review of all adverse rulings relating to its Motion for Relief and Sanctions; Defendants’ Motions for Summary Judgment; determining that certain matters were not trade secrets; Defendants’ joint and several liability; preemption under the Kansas Uniform Trade Secrets Act; motions in limine; motions for judgment as a matter of law; jury instructions; admission of evidence over its objections; and all other ruling adverse to it only if the court reverses the jury verdict and judgment. Aeroflex Wichita also reserved the right to ask the reviewing court to order a new trial either on damages alone or on liability for all claims. This reservation of rights is also contingent upon a finding of the appellate court which would reverse the jury verdict and judgment. Aeroflex Wichita filed its Docketing Statement the same day. On July 11, 2018, the Court of Appeals entered an Order of Referral to Mediation and Order to Stay. The Company’s case was selected to participate in the Kansas Court of Appeals Appellate Mediation pilot program. Participation in the program is voluntary, either party may opt out of participation. The order staying the case was lifted because Aeroflex Wichita, Inc. opted out, and as a result the appeal will proceed under normal procedures. Other than the matters outlined above, we are currently not involved in any litigation that we believe could have a material adverse effect on our financial condition or results of operations. There is no action, suit, proceeding, inquiry or investigation before any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of executive officers of our Company, threatened against or affecting our Company, or our common stock in which an adverse decision could have a material effect. |
Note 15 - New Accounting Pronou
Note 15 - New Accounting Pronouncements | 6 Months Ended |
Sep. 30, 2018 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
New Accounting Pronouncements and Changes in Accounting Principles [Text Block] | Note 15 – New Accounting Pronouncements Recently Adopted Authoritative Pronouncements Revenue Recognition In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers: Topic 606 The Company generates revenue from designing, manufacturing and selling avionic tests and measurement solutions for the global commercial air transport, general aviation, and government/military aerospace and defense markets. The Company also offers calibration and repair services for a wide range of airborne navigation and communication equipment. Under Financial Accounting Standards Board (“FASB”) Topic 606, Revenue from Contacts with Customers Nature of goods and services The following is a description of the products and services from which the Company generates revenue, as well as the nature, timing of satisfaction of performance obligations, and significant payment terms for each. Test Units/Sets The Company develops, and manufactures unit sets to test navigation and communication equipment, such as ramp testers and bench testers for radios installed in aircraft. The Company recognizes revenue when the customer obtains control of the Company’s product based on the contractual shipping terms of the contract. Revenue on products are presented gross because the Company is primarily responsible for fulfilling the promise to provide the product, is responsible to ensure that the product is produced in accordance with the related supply agreement, and bears the risk of loss while the inventory is in-transit. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products to the customer. If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price based on the estimated relative standalone selling prices of the promised products or services underlying each performance obligation. The Company determines stand-alone selling prices based on the price at which the performance obligation is sold separately. If the stand-alone selling price is not observable through past transactions, the Company estimates the standalone selling price taking into account available information such as market conditions and internally approved pricing guidelines related to the performance obligations. When determining the transaction price of a contract, an adjustment is made if payment from the customer occurs either significantly before or significantly after performance, resulting in a significant financing component. Applying the practical expedient in paragraph 606-10-32-18, the Company does not assess whether a significant financing component exists if the period between when the Company performs its obligations under the contract and when the customer pays is one year or less. None of the Company’s contracts contained a significant financing component as of September 30, 2018. Replacement Parts The Company offers replacement parts for test equipment, ramp testers, and bench testers. Similar to the sale of test units, the control of the product transfers at a point of time and therefore, revenue is recognized at the point in time when the obligation to the customer has been fulfilled. Extended Warranties The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms generally ranging from 5 to 7 years. Amounts received for warranties are recorded as deferred revenue and recognized as revenue ratably over the respective term of the agreements. As of September 30, 2018, approximately $640,690 is expected to be recognized from remaining performance obligations for extended warranties. For the six months ended September 30, 2018, the Company recognized revenue of $19,621 from amounts that were included in Deferred Revenue. Repair and Calibration Services The Company offers repair and calibration services for units that are returned for annual calibrations and/or for repairs after the warranty period has expired. The Company repairs and calibrates a wide range of airborne navigation and communication equipment. Revenue is recognized at the time the repaired or calibrated unit is shipped, as it is at this time that the work is completed. The majority of the Company’s revenues are from contracts with the U.S. government, airlines, aircraft manufacturers, such as Boeing and Lockheed Martin, domestic distributors, international distributors for sales to military and commercial customers, and other commercial customers. The contracts with the U.S. government typically are subject to the Federal Acquisition Regulation (“FAR”) which provides guidance on the types of costs that are allowable in establishing prices for goods and services provided under U.S. government contracts. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within a range from 30 to 60 days, or in certain cases, up-front deposits. In circumstances where the timing of revenue recognition differs from the timing of invoicing, the Company has determined that the Company's contracts generally do not include a significant financing component. Payments received prior to the delivery of units or services performed are recorded as deferred revenues. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from sales. Shipping and handling costs charged to customers are classified as sales, and the shipping and handling costs incurred are included in cost of sales. Disaggregation of revenue In the following table, revenue is disaggregated by revenue category. For the Three Months Ended September 30, 2018 Commercial Government Sales Distribution Test Units $ 261,992 $ 1,284,099 Repairs and Calibration 586,577 - Replacement Parts 79,586 - Extended Warranty 10,687 - $ 938,842 $ 1,284,099 Disaggregation of revenue For the Six Months Ended September 30, 2018 Commercial Government Sales Distribution Test Units $ 596,224 $ 2,376,681 Repairs and Calibration 919,276 - Replacement Parts 125,354 - Extended Warranty 19,620 - $ 1,660,474 $ 2,376,681 In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) No other recently issued accounting pronouncements had or are expected to have a material impact on the Company’s consolidated financial statements. |
Note 16 - Subsequent Event
Note 16 - Subsequent Event | 6 Months Ended |
Sep. 30, 2018 | |
Subsequent Events [Abstract] | |
Subsequent Events [Text Block] | Note 1 6 – Subsequent Event On October 2, 2018, the Company established 166,667 shares of the Company’s the Series B Convertible Preferred Stock (the “ Series B Preferred On October 5, 2018, the Company entered into a definitive subscription agreement with an accredited investor, pursuant to which the investor purchased an aggregate of 166,667 shares of the Company’s Series B Preferred Stock for $1 million. The Company intends to use such proceeds for working capital purposes. |
Note 4 - Accounts Receivable,_2
Note 4 - Accounts Receivable, net (Tables) | 6 Months Ended |
Sep. 30, 2018 | |
Receivables [Abstract] | |
Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] | The following table sets forth the components of accounts receivable: September 30, 2018 March 31, 2018 Government $ 436,180 $ 998,522 Commercial 340,873 104,027 Less: Allowance for doubtful accounts (7,500 ) (7,500 ) $ 769,553 $ 1,095,049 |
Note 6 - Inventories, net (Tabl
Note 6 - Inventories, net (Tables) | 6 Months Ended |
Sep. 30, 2018 | |
Inventory Disclosure [Abstract] | |
Schedule of Inventory, Current [Table Text Block] | Inventories consist of: September 30, 2018 March 31, 2018 Purchased parts $ 2,956,459 $ 3,571,874 Work-in-process 1,254,607 1,051,725 Finished goods 16,098 66,335 Less: Inventory reserve (465,000 ) (420,000 ) $ 3,762,164 $ 4,269,934 |
Note 7 - Net Loss per Share (Ta
Note 7 - Net Loss per Share (Tables) | 6 Months Ended |
Sep. 30, 2018 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] | Three Months Ended Three Months Ended September 30, 2018 September 30, 2017 Basic net loss per share computation: Net loss $ (191,410 ) $ (2,920,589 ) Add: Preferred dividends (60,000 ) - Net loss attributable to common shareholders (251,410 ) (2,920,589 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Basic net loss per share $ (0.08 ) $ (0.90 ) Diluted net loss per share computation Net loss income $ (191,410 ) $ (2,920,589 ) Add: Preferred dividends (60,000 ) - Diluted loss income $ (251,410 ) (2,920,589 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Incremental shares attributable to the assumed exercise of outstanding stock options and warrants - - Total adjusted weighted-average shares 3,255,887 3,255,887 Diluted net loss per share $ (0.08 ) $ (0.90 ) Six Months Ended Six Months Ended Septe mber 30, 2018 September 30, 2017 Basic net loss per share computation: Net loss $ (937,483 ) $ (3,206,680 ) Add: Preferred dividends (120,000 ) - Net loss attributable to common shareholders (1,057,483 ) (3,206,680 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Basic net income per share $ (0.32 ) $ (0.98 ) Diluted net loss per share computation Net loss $ (937,483 ) $ (3,206,680 ) Add: Preferred dividends (120,000 ) - Diluted loss attributable to common shareholders $ (1,057,483 ) (3,206,680 ) Weighted-average common shares outstanding 3,255,887 3,255,887 Incremental shares attributable to the assumed exercise of outstanding stock options and warrants - - Total adjusted weighted-average shares 3,255,887 3,255,887 Diluted net loss per share $ (0.32 ) $ (0.98 ) |
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] | The following table summarizes securities that, if exercised, would have an anti-dilutive effect on earnings per share: September 30, 2018 September 30, 2017 Convertible preferred stock 1,070,222 - Stock options 42,500 77,000 Warrants 50,000 50,000 1,162,722 127,000 |
Note 10 - Segment Information (
Note 10 - Segment Information (Tables) | 6 Months Ended |
Sep. 30, 2018 | |
Segment Reporting [Abstract] | |
Schedule of Segment Reporting Information, by Segment [Table Text Block] | The table below presents information about reportable segments within the avionics business for the three and six month periods ending September 30, 2018 and 2017: Three Months Ended September 30, 2018 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 1,284,099 $ 938,842 $ 2,222,941 $ - $ 2,222,941 Cost of sales 714,590 509,138 1,223,728 - 1,223,728 Gross margin 569,509 429,704 999,213 - 999,213 Engineering, research, and development 503,380 - 503,380 Selling, general and administrative 194,179 361,232 555,411 Litigation costs 35,848 35,848 Interest income - (1,009 ) (1,009 ) Interest expense - judgment 72,003 72,003 Interest expense - 24,990 24,990 Total expenses 697,559 493,064 1,190,623 Income (loss) before income taxes $ 301,654 $ (493,064 ) $ (191,410 ) Three Months Ended September 30, 2017 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 1,028,693 $ 758,472 $ 1,787,165 $ - $ 1,787,165 Cost of sales 660,589 726,706 1,387,295 - 1,387,295 Gross margin 368,104 31,766 399,870 - 399,870 Engineering, research, and development 529,667 - 529,667 Selling, general and administrative 277,518 348,877 626,395 Litigation costs 43,333 43,333 Legal damages 2,100,000 2,100,000 Amortization of deferred financing costs - 1,357 1,357 Change in fair value of common stock warrants - 5,000 5,000 Proceeds from life insurance - - Interest expense, net - 14,707 14,707 Total expenses 807,185 2,513,274 3,320,459 Loss before income taxes $ (407,315 ) $ (2,513,274 ) $ (2,920,589 ) Six Months Ended September 30, 2018 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 2,376,681 $ 1,660,474 $ 4,037,155 $ - $ 4,037,155 Cost of sales 1,475,844 1,080,785 2,556,629 - 2,556,629 Gross margin 900,837 579,689 1,480,526 - 1,480,526 Engineering, research, and development 1,020,703 - 1,020,703 Selling, general and administrative 411,307 710,629 1,121,936 Litigation costs 75,119 75,119 Interest income - (2,007 ) (2,007 ) Interest expense - judgment 143,223 143,223 Interest expense - 59,035 59,035 Total expenses 1,432,010 985,999 2,418,009 Income (loss) before income taxes $ 48,516 $ (985,999 ) $ (937,483 ) Six Months Ended September 30, 2017 Avionics Government Avionics Commercial Avionics Total Corporate Items Total Net sales $ 4,001,019 $ 1,328,223 $ 5,329,242 $ - $ 5,329,242 Cost of sales 2,475,742 1,212,340 3,688,082 - 3,688,082 Gross margin 1,525,277 115,883 1,641,160 - 1,641,160 Engineering, research, and development 1,144,940 - 1,144,940 Selling, general and administrative 636,185 696,496 1,332,681 Litigation costs 425,845 425,845 Legal damages 2,100,000 2,100,000 Amortization of deferred financing costs - 2,714 2,714 Change in fair value of common stock warrants - (90,000 ) (90,000 ) Proceeds from life insurance (92,678 ) (92,678 ) Interest expense, net - 24,338 24,338 Total expenses 1,781,125 3,066,715 4,847,840 Loss before income taxes $ (139,965 ) $ (3,066,715 ) $ (3,206,680 ) |
Note 15 - New Accounting Pron_2
Note 15 - New Accounting Pronouncements (Tables) | 6 Months Ended |
Sep. 30, 2018 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Schedule of New Accounting Pronouncements and Changes in Accounting Principles [Table Text Block] | In the following table, revenue is disaggregated by revenue category. For the Three Months Ended September 30, 2018 Commercial Government Sales Distribution Test Units $ 261,992 $ 1,284,099 Repairs and Calibration 586,577 - Replacement Parts 79,586 - Extended Warranty 10,687 - $ 938,842 $ 1,284,099 For the Six Months Ended September 30, 2018 Commercial Government Sales Distribution Test Units $ 596,224 $ 2,376,681 Repairs and Calibration 919,276 - Replacement Parts 125,354 - Extended Warranty 19,620 - $ 1,660,474 $ 2,376,681 |
Note 2 - Liquidity and Going _2
Note 2 - Liquidity and Going Concern (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
Oct. 31, 2017 | Mar. 31, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Mar. 31, 2018 | |
Note 2 - Liquidity and Going Concern (Details) [Line Items] | |||||||
Net Income (Loss) Attributable to Parent | $ (191,410) | $ (2,920,589) | $ (937,483) | $ (3,206,680) | $ (4,322,311) | ||
Estimated Litigation Liability | 5,144,644 | 5,144,644 | |||||
Restricted Cash, Current | 2,002,873 | 2,002,873 | $ 2,000,866 | ||||
Stock Issued During Period, Shares, New Issues (in Shares) | 166,667 | ||||||
Proceeds from Issuance or Sale of Equity | $ 1,000,000 | ||||||
Aeroflex [Member] | |||||||
Note 2 - Liquidity and Going Concern (Details) [Line Items] | |||||||
Loss Contingency, Damages Awarded, Value | $ 2,100,000 | $ 2,800,000 | |||||
Restricted Cash, Current | $ 2,000,000 | $ 2,000,000 | |||||
Aeroflex [Member] | |||||||
Note 2 - Liquidity and Going Concern (Details) [Line Items] | |||||||
Loss Contingency, Damages Awarded, Value | $ 2,100,000 | $ 2,800,000 |
Note 4 - Accounts Receivable,_3
Note 4 - Accounts Receivable, net (Details) - Schedule of Accounts, Notes, Loans and Financing Receivable - USD ($) | Sep. 30, 2018 | Mar. 31, 2018 |
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Less: Allowance for doubtful accounts | $ (7,500) | $ (7,500) |
Accounts Receivable, net | 769,553 | 1,095,049 |
Government Receivables [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Accounts Receivable | 436,180 | 998,522 |
Commercial Receivables [Member] | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Accounts Receivable | $ 340,873 | $ 104,027 |
Note 5 - Restricted Cash to s_2
Note 5 - Restricted Cash to support appeal bond (Details) | Sep. 30, 2018USD ($) |
Aeroflex [Member] | |
Note 5 - Restricted Cash to support appeal bond (Details) [Line Items] | |
Restricted Cash, Current | $ 2,000,000 |
Note 6 - Inventories, net (Det
Note 6 - Inventories, net (Details) - Schedule of Inventory, Current - USD ($) | Sep. 30, 2018 | Mar. 31, 2018 |
Schedule of Inventory, Current [Abstract] | ||
Purchased parts | $ 2,956,459 | $ 3,571,874 |
Work-in-process | 1,254,607 | 1,051,725 |
Finished goods | 16,098 | 66,335 |
Less: Inventory reserve | (465,000) | (420,000) |
$ 3,762,164 | $ 4,269,934 |
Note 7 - Net Loss per Share (De
Note 7 - Net Loss per Share (Details) - Schedule of Earnings Per Share, Basic and Diluted - USD ($) | 3 Months Ended | 6 Months Ended | 12 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | Mar. 31, 2018 | |
Basic net loss per share computation: | |||||
Net loss income | $ (191,410) | $ (2,920,589) | $ (937,483) | $ (3,206,680) | $ (4,322,311) |
Add: Preferred dividends | (60,000) | 0 | (120,000) | 0 | |
Diluted loss income | (251,410) | (2,920,589) | (1,057,483) | (3,206,680) | |
Net loss attributable to common shareholders | $ (251,410) | $ (2,920,589) | $ (1,057,483) | $ (3,206,680) | |
Weighted-average common shares outstanding (in Shares) | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 | |
Incremental shares attributable to the assumed exercise of outstanding stock options and warrants (in Shares) | 0 | 0 | 0 | 0 | |
Total adjusted weighted-average shares (in Shares) | 3,255,887 | 3,255,887 | 3,255,887 | 3,255,887 | |
Diluted net loss per share (in Dollars per share) | $ (0.08) | $ (0.90) | $ (0.32) | $ (0.98) | |
Basic net loss per share (in Dollars per share) | $ (0.08) | $ (0.90) | $ (0.32) | $ (0.98) |
Note 7 - Net Loss per Share (_2
Note 7 - Net Loss per Share (Details) - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share - shares | 6 Months Ended | |
Sep. 30, 2018 | Sep. 30, 2017 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-Dilutive Securities | 1,162,722 | 127,000 |
Convertible Preferred Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-Dilutive Securities | 1,070,222 | 0 |
Employee Stock Option [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-Dilutive Securities | 42,500 | 77,000 |
Warrant [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-Dilutive Securities | 50,000 | 50,000 |
Note 8 - Long-Term Debt (Detail
Note 8 - Long-Term Debt (Details) - Notes Payable to Banks [Member] - Note to Bank #1 [Member] - USD ($) | 1 Months Ended | ||
Jul. 31, 2015 | Sep. 30, 2018 | Mar. 31, 2018 | |
Note 8 - Long-Term Debt (Details) [Line Items] | |||
$ 18,000 | |||
Debt Instrument, Term | 3 years | ||
Debt Instrument, Maturity Date, Description | July 2,018 | ||
Debt Instrument, Frequency of Periodic Payment | Monthly | ||
Debt Instrument, Periodic Payment | $ 536 | ||
Debt Instrument, Interest Rate, Stated Percentage | 4.50% | ||
Debt Instrument, Collateral | collateralized by substantially all of the assets of the Company | ||
Notes Payable | $ 0 | $ 2,124 |
Note 9 - Line of Credit (Detail
Note 9 - Line of Credit (Details) - Line of Credit [Member] - USD ($) | Aug. 29, 2018 | Mar. 31, 2017 | Sep. 30, 2018 | Mar. 31, 2018 |
Note 9 - Line of Credit (Details) [Line Items] | ||||
Line of Credit Facility, Expiration Date | May 31, 2019 | Mar. 31, 2018 | ||
Line of Credit Facility, Maximum Borrowing Capacity | $ 1,000,000 | |||
Repayments of Long-term Lines of Credit | $ 100,000 | |||
Long-term Line of Credit | 900,000 | $ 840,000 | $ 1,000,000 | |
Line of Credit Facility, Periodic Payment | $ 50,000 | |||
Line of Credit Facility, Interest Rate at Period End | 5.915% | |||
Debt Instrument, Payment Terms | The Company will make principal payments of $5,000 per month from September 30, 2018 through November 30, 2018 and principal payments of $10,000 per month from December 31, 2018 to May 31, 2019. | |||
Repayments of Lines of Credit | $ 160,000 | |||
Line of Credit Facility, Remaining Borrowing Capacity | $ 0 | |||
London Interbank Offered Rate (LIBOR) [Member] | ||||
Note 9 - Line of Credit (Details) [Line Items] | ||||
Debt Instrument, Basis Spread on Variable Rate | 3.75% |
Note 10 - Segment Information_2
Note 10 - Segment Information (Details) | 6 Months Ended |
Sep. 30, 2018 | |
Segment Reporting [Abstract] | |
Number of Reportable Segments | 2 |
Note 10 - Segment Information
Note 10 - Segment Information (Details) - Schedule of Segment Reporting Information, by Segment - USD ($) | 3 Months Ended | 6 Months Ended | ||
Sep. 30, 2018 | Sep. 30, 2017 | Sep. 30, 2018 | Sep. 30, 2017 | |
Segment Reporting Information [Line Items] | ||||
Net sales | $ 2,222,941 | $ 1,787,165 | $ 4,037,155 | $ 5,329,242 |
Cost of sales | 1,223,728 | 1,387,295 | 2,556,629 | 3,688,082 |
Gross margin | 999,213 | 399,870 | 1,480,526 | 1,641,160 |
Engineering, research, and development | 503,380 | 529,667 | 1,020,703 | 1,144,940 |
Selling, general and administrative | 555,411 | 626,395 | 1,121,936 | 1,332,681 |
Litigation costs | 35,848 | 43,333 | 75,119 | 425,845 |
Legal damages | 2,100,000 | 2,100,000 | ||
Amortization of deferred financing costs | 0 | 1,357 | 0 | 2,714 |
Change in fair value of common stock warrants | 0 | 5,000 | 0 | (90,000) |
Proceeds from life insurance | 0 | 0 | 0 | (92,678) |
Interest income | (1,009) | 0 | (2,007) | 0 |
Interest expense - judgment | 72,003 | 0 | 143,223 | 0 |
Interest expense, net | 24,990 | 14,707 | 59,035 | 24,338 |
Total expenses | 1,190,623 | 3,320,459 | 2,418,009 | 4,847,840 |
Income (loss) before income taxes | (191,410) | (2,920,589) | (937,483) | (3,206,680) |
Avionics Government [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 1,284,099 | 1,028,693 | 2,376,681 | 4,001,019 |
Cost of sales | 714,590 | 660,589 | 1,475,844 | 2,475,742 |
Gross margin | 569,509 | 368,104 | 900,837 | 1,525,277 |
Avionics Commercial [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 938,842 | 758,472 | 1,660,474 | 1,328,223 |
Cost of sales | 509,138 | 726,706 | 1,080,785 | 1,212,340 |
Gross margin | 429,704 | 31,766 | 579,689 | 115,883 |
Avionics Total [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 2,222,941 | 1,787,165 | 4,037,155 | 5,329,242 |
Cost of sales | 1,223,728 | 1,387,295 | 2,556,629 | 3,688,082 |
Gross margin | 999,213 | 399,870 | 1,480,526 | 1,641,160 |
Engineering, research, and development | 503,380 | 529,667 | 1,020,703 | 1,144,940 |
Selling, general and administrative | 194,179 | 277,518 | 411,307 | 636,185 |
Amortization of deferred financing costs | 0 | 0 | ||
Change in fair value of common stock warrants | 0 | 0 | ||
Interest income | 0 | 0 | ||
Interest expense, net | 0 | 0 | 0 | 0 |
Total expenses | 697,559 | 807,185 | 1,432,010 | 1,781,125 |
Income (loss) before income taxes | 301,654 | (407,315) | 48,516 | (139,965) |
Corporate Segment [Member] | ||||
Segment Reporting Information [Line Items] | ||||
Net sales | 0 | 0 | 0 | 0 |
Cost of sales | 0 | 0 | 0 | 0 |
Gross margin | 0 | 0 | 0 | 0 |
Engineering, research, and development | 0 | 0 | 0 | 0 |
Selling, general and administrative | 361,232 | 348,877 | 710,629 | 696,496 |
Litigation costs | 35,848 | 43,333 | 75,119 | 425,845 |
Legal damages | 2,100,000 | 2,100,000 | ||
Amortization of deferred financing costs | 1,357 | 2,714 | ||
Change in fair value of common stock warrants | 5,000 | (90,000) | ||
Proceeds from life insurance | 0 | (92,678) | ||
Interest income | (1,009) | (2,007) | ||
Interest expense - judgment | 72,003 | 143,223 | ||
Interest expense, net | 24,990 | 14,707 | 59,035 | 24,338 |
Total expenses | 493,064 | 2,513,274 | 985,999 | 3,066,715 |
Income (loss) before income taxes | $ (493,064) | $ (2,513,274) | $ (985,999) | $ (3,066,715) |
Note 11 - Income Taxes (Details
Note 11 - Income Taxes (Details) $ in Millions | Sep. 30, 2018USD ($) |
Income Tax Disclosure [Abstract] | |
Deferred Tax Assets, Valuation Allowance | $ 3.5 |
Note 12 - Fair Value Measurem_2
Note 12 - Fair Value Measurements (Details) - Warrants Held by Outside Investor [Member] - USD ($) | Sep. 30, 2018 | Mar. 31, 2018 |
Note 12 - Fair Value Measurements (Details) [Line Items] | ||
Warrants and Rights Outstanding | $ 50,000 | |
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share) | $ 3.35 | |
Derivative Liability, Noncurrent | $ 0 |
Note 13 - Series A 8% Convert_2
Note 13 - Series A 8% Convertible Preferred Stock (Details) - Series A Preferred Stock [Member] - USD ($) | Nov. 14, 2017 | Mar. 31, 2018 |
Note 13 - Series A 8% Convertible Preferred Stock (Details) [Line Items] | ||
Stock Issued During Period, Shares, New Issues | 500,000 | |
Proceeds from Issuance of Convertible Preferred Stock | $ 3,000,000 | |
Preferred Stock, Par or Stated Value Per Share | $ 6 | |
Convertible Preferred Stock, Conversion Price | $ 3 | |
Preferred Stock, Dividend Rate, Percentage | 8.00% | |
Preferred Stock, Conversion Basis | calculated on the basis of a 360 day year, consisting of twelve 30-day months, and shall accrue from the date of issuance of such shares of Series A Preferred, payable quarterly in cash | |
Dividends Payable, Current | $ 90,667 |
Note 14 - Litigation (Details)
Note 14 - Litigation (Details) - Aeroflex [Member] - USD ($) | 1 Months Ended | ||
Jan. 31, 2018 | Oct. 31, 2017 | Mar. 31, 2017 | |
Note 14 - Litigation (Details) [Line Items] | |||
Loss Contingency, Damages Awarded, Value | $ 2,100,000 | $ 2,800,000 | |
Loss Contingency, Estimate of Possible Loss | $ 4,900,000 | ||
Loss Contingency, Damages Sought | The Company filed motions in January 2018 for the Court to reconsider the amount of damages on the grounds that they are duplicative and not legally supportable. A hearing on this motion was held. The Judge rejected all of our arguments and declined to order a new trial. We filed the appeal document the week of May 28. The Company has posted a $2,000,000 bond. This $2 million bond amount will remain in place during the appeal process (See Note 5). The Company believes it has solid grounds to appeal this verdict. The appeal process is anticipated to take several years to complete. | ||
Restricted Cash | $ 2,000,000 | ||
Business Opportunity [Member] | |||
Note 14 - Litigation (Details) [Line Items] | |||
Loss Contingency, Damages Awarded, Value | 1,300,000 | ||
Non-Disclosure Agreements [Member] | |||
Note 14 - Litigation (Details) [Line Items] | |||
Loss Contingency, Damages Awarded, Value | 525,000 | ||
Loss Contingency, Damages Sought, Value | 1,500,000 | ||
Maximum [Member] | |||
Note 14 - Litigation (Details) [Line Items] | |||
Loss Contingency, Damages Sought, Value | $ 5,000,000 |
Note 15 - New Accounting Pron_3
Note 15 - New Accounting Pronouncements (Details) | 6 Months Ended |
Sep. 30, 2018USD ($) | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | |
Extended Product Warranty Description | terms generally ranging from 5 to 7 years |
Extended Product Warranty Accrual | $ 640,690 |
Recognition of Deferred Revenue | $ 19,621 |
Note 15 - New Accounting Pron_4
Note 15 - New Accounting Pronouncements (Details) - Schedule of Changes in Accounting Principals - USD ($) | 3 Months Ended | 6 Months Ended |
Sep. 30, 2018 | Sep. 30, 2018 | |
Commercial [Member] | ||
Sales Distribution | ||
Sales by revenue category | $ 938,842 | $ 1,660,474 |
Government Sales [Member] | ||
Sales Distribution | ||
Sales by revenue category | 1,284,099 | 2,376,681 |
Test Units [Member] | Commercial [Member] | ||
Sales Distribution | ||
Sales by revenue category | 261,992 | 596,224 |
Test Units [Member] | Government Sales [Member] | ||
Sales Distribution | ||
Sales by revenue category | 1,284,099 | 2,376,681 |
Repairs and Calibration [Member] | Commercial [Member] | ||
Sales Distribution | ||
Sales by revenue category | 586,577 | 919,276 |
Repairs and Calibration [Member] | Government Sales [Member] | ||
Sales Distribution | ||
Sales by revenue category | 0 | 0 |
Replacement Parts [Member] | Commercial [Member] | ||
Sales Distribution | ||
Sales by revenue category | 79,586 | 125,354 |
Replacement Parts [Member] | Government Sales [Member] | ||
Sales Distribution | ||
Sales by revenue category | 0 | 0 |
Extended Warranty [Member] | Commercial [Member] | ||
Sales Distribution | ||
Sales by revenue category | 10,687 | 19,620 |
Extended Warranty [Member] | Government Sales [Member] | ||
Sales Distribution | ||
Sales by revenue category | $ 0 | $ 0 |
Note 16 - Subsequent Event (Det
Note 16 - Subsequent Event (Details) - Subsequent Event [Member] - Series B Preferred Stock [Member] - USD ($) $ / shares in Units, $ in Millions | Oct. 05, 2018 | Oct. 02, 2018 |
Note 16 - Subsequent Event (Details) [Line Items] | ||
Preferred Stock, Shares Authorized | 166,667 | |
Preferred Stock, Par or Stated Value Per Share (in Dollars per share) | $ 6 | |
Preferred Stock, Conversion Basis | convertible into Common Stock at a price of $2.00 per share | |
Preferred Stock, Dividend Rate, Percentage | 8.00% | |
Stock Issued During Period, Shares, New Issues | 166,667 | |
Stock Issued During Period, Value, New Issues (in Dollars) | $ 1 |